SEC 13F Intelligence

Macro Consulting Group / ABT

Macro Consulting Group’s Abbott Laboratories Position

Does Macro Consulting Group own Abbott Laboratories (ABT)? Yes — 17.3K shares worth $2M (+1.03% of its 13F portfolio) as of Q2 2021, up from 17.2K shares the prior filed quarter.

Position Value
$2M
Q2 2021
Shares
17.3K
% of Portfolio
+1.03%
Quarters Held
11
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $2MQ4 ’18Q1 ’19: $2MQ2 ’19: $2MQ2 ’19Q3 ’19: $2MQ4 ’19: $2MQ4 ’19Q1 ’20: $2MQ2 ’20: $2MQ2 ’20Q3 ’20: $2MQ4 ’20: $2MQ4 ’20Q1 ’21: $2MQ2 ’21: $2MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202117.3K$2M+1.03%
Q1 202117.2K$2M+1.11%
Q4 202017.4K$2M+1.11%
Q3 202017.2K$2M+1.19%
Q2 202022.9K$2M+1.45%
Q1 202023.1K$2M+1.66%
Q4 201922.0K$2M+1.51%
Q3 201921.1K$2M+1.51%
Q2 201921.0K$2M+1.51%
Q1 201922.5K$2M+1.72%
Q4 201826.1K$2M+1.84%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Macro Consulting Group’s full portfolio or all institutional holders of ABT.